Droplet Digital PCR Outperforms Conventional Methods for Early Relapse Prediction in AML/MDS Patients Posttransplantation [0.03%]
移植后 droplet 数字 PCR 优于传统方法预测 MDS/AML 患者早期复发
Xiao Zhou,Ying Wang,Yu Cai et al.
Xiao Zhou et al.
Background: Relapse remains a major challenge after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for myeloid malignancies. Early detection of relapse is critical for timely intervention, and measurable r...
Fludarabine Pharmacokinetic Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Allogeneic Hematopoietic Cell Transplantation [0.03%]
基于氟达拉滨药代动力学模型的给药最小化异基因造血干细胞移植患儿移植物排斥风险
Christopher C Dvorak,Ella Waters,William C Temple et al.
Christopher C Dvorak et al.
Background: Fludarabine is commonly used during conditioning for allogeneic hematopoietic cell transplantation (HCT) to prevent rejection of donor cells given its profound immunosuppressive effects on T cells, albeit with...
Cladribine as an Alternative to Fludarabine in Melphalan and Total Body Irradiation Based Reduced Intensity Conditioning [0.03%]
用于减强度预处理的马法兰和全身照射方案中克来德abin作为氟达拉滨的替代品
Ugur Sahin,Selin Merih Urlu,Ayla Gokmen et al.
Ugur Sahin et al.
Background and objectives: Drug shortages, such as the fludarabine (FLU) shortage during the COVID-19 pandemic, necessitate finding alternative agents for allogeneic stem cell transplantation (ASCT) conditioning regimens....
Toward Optimized Real-World Lymphodepletion in Idecabtagene Vicleucel (Ide-cel) Therapy: Lessons from Fludarabine Exposure in Multiple Myeloma [0.03%]
优化实际环境下的Idecabtagene Vicleucel(Ide-cel)治疗预处理方案：氟达拉滨在多发性骨髓瘤中的暴露经验教训
Guillaume Dachy,Xavier Poiré
Guillaume Dachy
Bruce R Blazar
Bruce R Blazar
Evolution of the ASTCT's Journal Transplantation and Cellular Therapy [0.03%]
《ASTCT期刊Transplantation and Cellular Therapy的演变》
Richard J O&#x;Reilly
Richard J O&#x;Reilly
Post Hematopoietic Cell Transplantation Maintenance Therapy with Low-Dose Azacitidine in a Pediatric Population with High-Risk Myeloid Malignancies [0.03%]
低剂量地西他滨用于高危髓系恶性肿瘤儿童患者造血干细胞移植后维持治疗的一项研究
Emily C Merkel,Ted Gooley,Monica S Thakar et al.
Emily C Merkel et al.
Background: Patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) with high-risk features undergoing hematopoietic cell transplantation (HCT) experience high rates of relapse. Hypomethylating agen...
REGIONAL DISPARITIES AND SOCIOECONOMIC FACTORS AFFECTING OUTCOMES OF HEMATOPOIETIC CELL TRANSPLANTATION IN BRAZIL: INSIGHTS FROM THE BRAZILIAN BONE MARROW TRANSPLANT MAP [0.03%]
巴西造血细胞移植结果的地区差异及社会经济因素：来自巴西骨髓移植地图的见解
Giancarlo Fatobene,Carmen Vergueiro,Anderson João Simione et al.
Giancarlo Fatobene et al.
Introduction: The Brazilian Bone Marrow Transplant Map (BMTM) provides public data on hematopoietic cell transplantation (HCT) in Brazil. Objective: ...
Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival After Second Allogeneic Stem Cell Transplantation [0.03%]
新的评分系统使用老年营养风险指数、C-反应蛋白和疾病状态预测第二次allo-HSCT后生存率
Yasutaka Sadaga,Yuho Najima,Takayoshi Tachibana et al.
Yasutaka Sadaga et al.
Second allogeneic stem cell transplantation (SCT2) is a potentially curative treatment for relapsed hematological malignancies; however, its outcomes generally remain poor. In this multicenter retrospective study, we aimed to validate the G...